2018
DOI: 10.1186/s13046-018-0752-0
|View full text |Cite
|
Sign up to set email alerts
|

Patient-derived multicellular tumor spheroids towards optimized treatment for patients with hepatocellular carcinoma

Abstract: BackgroundHepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide and has poor prognosis. Specially, patients with HCC usually have poor tolerance of systemic chemotherapy, because HCCs develop from chronically damaged tissue that contains considerable inflammation, fibrosis, and cirrhosis. Since HCC exhibits highly heterogeneous molecular characteristics, a proper in vitro system is required for the study of HCC pathogenesis. To this end, we have established two new hepatitis B vir… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
40
0
2

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 52 publications
(45 citation statements)
references
References 29 publications
3
40
0
2
Order By: Relevance
“…25–27 Moreover, primary cells isolated from patients cultured in 3D could maintain some special characteristics of cells in vivo for a long time in vitro. 9 All these findings imply that the response of 3D-cultured cells to antitumor drugs could better reflect the response of cells in vivo.…”
Section: Discussionmentioning
confidence: 96%
“…25–27 Moreover, primary cells isolated from patients cultured in 3D could maintain some special characteristics of cells in vivo for a long time in vitro. 9 All these findings imply that the response of 3D-cultured cells to antitumor drugs could better reflect the response of cells in vivo.…”
Section: Discussionmentioning
confidence: 96%
“…To address these issues, 3D cell culture models are a reliable alternative, providing experimentally accessible human models to study the biological processes of cancer. Several 3D culture platforms such as spheroids, organoids, hydrogels, 3D scaffolds, 3D bio-printing, and microfluidics have attempted the recreation of certain aspects of tumor microenvironments present in tissues including the brain [30][31][32][33][34][35][36], breast [37][38][39][40][41][42][43], ovarian [44][45][46][47][48][49][50][51], bone [52][53][54][55][56][57][58], liver [59][60][61][62][63][64][65], lung [66][67][68][69][70][71][72], colon [73][74][75][76]…”
Section: Mimicking Tme In Three-dimensionsmentioning
confidence: 99%
“…In order to devise 3D systems that more accurately reflect the molecular diversity of tumors and their respective TME, there was a need for protocols to promote the growth of spheroids and/or tumor organoids derived from cancer biopsies from patients (Song et al, 2018; Vlachogiannis et al, 2018). These patient derived tumor organoids are capable to recapitulate the molecular profile of the patients' tumors and have become a valuable platform for HTS of compounds and for personalization of therapy (van de Wetering et al, 2015; Vlachogiannis et al, 2018).…”
Section: Modeling the Tmementioning
confidence: 99%